Table 2 The Study Results

Number of patients -at 1^st month

26

29

0.2

-

-

-at 3^rd month

26

25

1.00

-at 6^th month

16

14

0.79

-at 12^th month

7

7

1.00

VA (logMAR ± SD) -at 3^rd m.

0.09 ± 0.20

0.09 ± 0.09

0.99

-

-

-at 6^th m.

0.05 ± 0.06

0.04 ± 0.06

0.60

-at 12^th m.

0.04 ± 0.05

0.03 ± 0.05

0.91

CMT (microns ± SD) -at 3^rd m.

220.65 ± 94.37

243.84 ± 76.13

0.34

-

-

-at 6^th m.

193.20 ± 46.38

183.22 ± 22.59

0.41

-at 12^th m.

180.00 ± 15.05

186.22 ± 20.62

0.42

Patients with subretinal fluid (number of patients)

-at 1^st month

22

23

0.73

-

-

-at 2^nd month

13

14

0.78

-

-

-at 3^rd month

3

10

0.027

0.196

0.046-0.830

Follow-up time (m ± SD)

9.04 ± 6.69

8.14 ± 8.69

0.67

-

-

FA leakage at 3^rd m. (patients)

3

10

0.027

0.196

0.046 - 0.830

- inkblot leakage

2

9

-

-

-

- smokestack leakage

1

1

0.94

-

-

Laser or PDT (number of patients)

4

11

0.03

0.231

0.061 - 0.872

Recurrence (number of patients)

1

2

0.29

-

-